Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

BACKGROUND: Combination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL) associated with this combination therapy when administered at first-line in advanced pancreatic adenocarcinoma is unknown. METHODS: A t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Yalcin, Suayib, Dane, Faysal, Oksuzoglu, Berna, Ozdemir, Nuriye Yildirim, Isikdogan, Abdurrahman, Ozkan, Metin, Demirag, Guzin Gonullu, Coskun, Hasan Senol, Karabulut, Bulent, Evrensel, Turkkan, Ustaoglu, Mehmet Ali, Ozdemir, Feyyaz, Turna, Hande, Yavuzsen, Tugba, Aykan, Faruk, Sevinc, Alper, Akbulut, Hakan, Yuce, Deniz, Hayran, Mutlu, Kilickap, Saadettin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7106641/
https://ncbi.nlm.nih.gov/pubmed/32228512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06758-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados